Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 20 mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Products
  • Duloxetine Delayed-Release Capsules USP 20 mg
Where it was sold

Nationwide

Nationwide

Units affected
73,680 bottles
About this recall
Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60